Recommended as an anticoagulant drug, Rivaroxaban is available as a first orally active direct factor Xa inhibitor. This drug competitively hinders with free and clot bound factor Xa that is required to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is actually a serine protease needed to activate fibrinogen to fibrin. This in turn looses the meshwork that completes the clotting process.
(S)-(+)-N-(2,3-Epoxypropyl) Phthalimide is prepared by combination of active compounds that are procured from reliable vendors. Furthermore, it is used for the preparation of Rivaroxaban.
Quality tested 2-[(2R)-2-Hydroxy-3-[[4-(3-Oxo-4-Morpholinyl) Phenyl]Amino]Propyl]-1H- Isoindole-1,3(2H)-Dione is used as an intermediate used for the preparation of Rivaroxaban. The processing is done under the strict guidance of skilled professionals at our manufac- turing unit, maintaining hygienic conditions.